Literature DB >> 17596304

A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses.

Takeo Kuwata1, Russell Byrum, Sonya Whitted, Robert Goeken, Alicia Buckler-White, Ronald Plishka, Ranjini Iyengar, Vanessa M Hirsch.   

Abstract

A subset of simian immunodeficiency virus (SIV)-infected macaques progresses rapidly to disease with transient SIV-specific immune responses and high viral loads. Unique SIV variants with convergent Env mutations evolve in these rapid progressor (RP) macaques. To address the pathogenic significance of RP-specific variants, we generated infectious molecular clones from the terminal-phase plasma of an RP macaque. Inoculation of macaques with a representative clone, SIVsmH635FC, resulted in a persistent viremia, comparable to that produced by pathogenic SIVsmE543-3, and a chronic disease with progressive loss of CD4(+) T cells. However, SIVsmH635FC did not reproduce the rapid-disease phenomenon. Molecular analyses of viruses from these macaques revealed rapid reversion to the wild-type SIVsmE543-3 sequence at two RP-specific sites and slower reversion at another three sites. SIVsmH635FC infection was not sufficient to cause rapid progression even following coinoculation with SIVsmE543-3, despite acute depletion of memory CD4(+) T cells. SIVsmH635FC competed efficiently during primary infection in the coinoculated macaques, but SIVsmE543-3 predominated after the development of SIV-specific immune responses. These data suggest that the replication fitness of the RP variant was similar to that of SIVsmE543-3 in a naïve host; however, SIVsmH635FC was at a disadvantage following the development of SIV-specific immune responses. Consistent with these findings, neutralization assays revealed that SIVsmH635FC was highly sensitive to neutralization but that the parental SIVsmE543-3 strain was highly resistant. This study suggests that the evolution of RP-specific variants is the result of replication in a severely immunocompromised host, rather than the direct cause of rapid progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596304      PMCID: PMC1951398          DOI: 10.1128/JVI.00614-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Infection with a molecularly cloned SIVsm virus elicits high titer homologous neutralizing antibodies with heterologous neutralizing activity.

Authors:  M Mahalanabis; V M Hirsch; N L Haigwood
Journal:  J Med Primatol       Date:  2005-10       Impact factor: 0.667

2.  Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

Authors:  Qingsheng Li; Lijie Duan; Jacob D Estes; Zhong-Min Ma; Tracy Rourke; Yichuan Wang; Cavan Reilly; John Carlis; Christopher J Miller; Ashley T Haase
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

3.  Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection.

Authors:  Ariko Miyake; Kentaro Ibuki; Yoshimi Enose; Hajime Suzuki; Reii Horiuchi; Makiko Motohara; Naoki Saito; Tadashi Nakasone; Mitsuo Honda; Toshiki Watanabe; Tomoyuki Miura; Masanori Hayami
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

4.  Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.

Authors:  Takeo Kuwata; Houman Dehghani; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Tatsuhiko Igarashi; Joseph Mattapallil; Mario Roederer; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Characterization of gut-associated lymphoid tissue (GALT) of normal rhesus macaques.

Authors:  R S Veazey; M Rosenzweig; D E Shvetz; D R Pauley; M DeMaria; L V Chalifoux; R P Johnson; A A Lackner
Journal:  Clin Immunol Immunopathol       Date:  1997-03

6.  Rapid and slow progressors differ by a single MHC class I haplotype in a family of MHC-defined rhesus macaques infected with SIV.

Authors:  D T Evans; L A Knapp; P Jing; J L Mitchen; M Dykhuizen; D C Montefiori; C D Pauza; D I Watkins
Journal:  Immunol Lett       Date:  1999-03       Impact factor: 3.685

7.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

8.  Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS.

Authors:  Charles R Brown; Meggan Czapiga; Juraj Kabat; Que Dang; Ilnour Ourmanov; Yoshiaki Nishimura; Malcolm A Martin; Vanessa M Hirsch
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

9.  Simian immunodeficiency virus infection of macaques: end-stage disease is characterized by widespread distribution of proviral DNA in tissues.

Authors:  V M Hirsch; P M Zack; A P Vogel; P R Johnson
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

10.  Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques.

Authors:  Yoshiaki Nishimura; Tatsuhiko Igarashi; Alicia Buckler-White; Charles Buckler; Hiromi Imamichi; Robert M Goeken; Wendy R Lee; Bernard A P Lafont; Russ Byrum; H Clifford Lane; Vanessa M Hirsch; Malcolm A Martin
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

View more
  11 in total

1.  A Potent anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Rhesus Macaques.

Authors:  Saori Matsuoka; Takeo Kuwata; Hiroshi Ishii; Tsuyoshi Sekizuka; Makoto Kuroda; Masato Sano; Midori Okazaki; Hiroyuki Yamamoto; Mikiko Shimizu; Shuzo Matsushita; Yohei Seki; Akatsuki Saito; Hiromi Sakawaki; Vanessa M Hirsch; Tomoyuki Miura; Hirofumi Akari; Tetsuro Matano
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

2.  Correction of a carboxyl terminal simian immunodeficiency virus Nef frameshift mutation restores virus replication in macaques.

Authors:  Yanfang Zheng; Ilnour Ourmanov; Robert M Goeken; Sonya Whitted; Charles R Brown; Alicia Buckler-White; Ranjini Iyengar; Ronald J Plishka; Vanessa M Hirsch
Journal:  Virology       Date:  2010-03-19       Impact factor: 3.616

3.  Sequential evolution and escape from neutralization of simian immunodeficiency virus SIVsmE660 clones in rhesus macaques.

Authors:  Fan Wu; Ilnour Ourmanov; Takeo Kuwata; Robert Goeken; Charles R Brown; Alicia Buckler-White; Ranjini Iyengar; Ronald Plishka; Scott T Aoki; Vanessa M Hirsch
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

4.  Intrathecal humoral responses are inversely associated with the frequency of simian immunodeficiency virus macrophage-tropic variants in the central nervous system.

Authors:  Elena Ryzhova; Pyone Aye; Tom Harvey; Wei Cao; Andrew Lackner; Francisco González-Scarano
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

5.  Conformational epitope consisting of the V3 and V4 loops as a target for potent and broad neutralization of simian immunodeficiency viruses.

Authors:  Takeo Kuwata; Kaori Takaki; Kazuhisa Yoshimura; Ikumi Enomoto; Fan Wu; Ilnour Ourmanov; Vanessa M Hirsch; Masaru Yokoyama; Hironori Sato; Shuzo Matsushita
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

6.  Genetic similarity of circulating and small intestinal virus at the end stage of acute pathogenic simian-human immunodeficiency virus infection.

Authors:  Megumi Matsuyama-Murata; Katsuhisa Inaba; Reii Horiuchi; Yoshinori Fukazawa; Kentaro Ibuki; Masanori Hayami; Tomoyuki Miura
Journal:  Front Microbiol       Date:  2013-07-22       Impact factor: 5.640

7.  Association of progressive CD4(+) T cell decline in SIV infection with the induction of autoreactive antibodies.

Authors:  Takeo Kuwata; Yoshiaki Nishimura; Sonya Whitted; Ilnour Ourmanov; Charles R Brown; Que Dang; Alicia Buckler-White; Ranjini Iyengar; Jason M Brenchley; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

8.  Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12.

Authors:  Rebecca L Dunfee; Elaine R Thomas; Dana Gabuzda
Journal:  Retrovirology       Date:  2009-07-20       Impact factor: 4.602

9.  Acquisition of CD4-dependence by CD4-independent SIV passaged in human peripheral blood mononuclear cells.

Authors:  Sujatha Iyengar; David H Schwartz
Journal:  Retrovirology       Date:  2012-07-25       Impact factor: 4.602

10.  Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses.

Authors:  Dawnnica Eastman; Anne Piantadosi; Xueling Wu; Donald N Forthal; Gary Landucci; Jason T Kimata; Julie Overbaugh
Journal:  Virol J       Date:  2008-08-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.